PALI 6

Generic Name: paliperidone

Pill imprint PALI 6 has been identified as Invega 6 mg.

Invega is used in the treatment of depression; schizophrenia; schizoaffective disorder; bipolar disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy.

Generic Name:

paliperidone

Inactive Ingredients:

• carnauba wax
• cellulose acetate
• polyethylene glycol
• propylene glycol
• povidone
• sodium chloride
• stearic acid
• butylated hydroxytoluene
• hypromelloses
• titanium dioxide
• ferrosoferric oxide

Drug Class:

Atypical antipsychotics

Pregnancy Category:

C – Risk cannot be ruled out

CSA Schedule:

N – Not a controlled drug

Manufacturer:

Janssen Pharmaceuticals

Pill imprint M 424 has been identified as Hydrochlorothiazide and metoprolol 25 mg / 50 mg.

Hydrochlorothiazide/metoprolol is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy.

Hydrochlorothiazide/metoprolol 25 mg / 50 mg is not subject to the Controlled Substances Act.

Inactive Ingredients:

• lactose anhydrous
• silicon dioxide
• croscarmellose sodium
• FD&C Yellow No. 6
• magnesium stearate
• microcrystalline cellulose
• povidone
• corn starch
• sodium lauryl sulfate

Drug Class:

Antihypertensive combinations

Pregnancy Category:

C – Risk cannot be ruled out

CSA Schedule:

N – Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

25 43 V

Pill imprint 25 43 V has been identified as Clonidine hydrochloride 0.3 mg.

Clonidine is used in the treatment of pain; adhd; high blood pressure; anxiety; opiate withdrawal (and more), and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy.

Clonidine 0.3 mg is not subject to the Controlled Substances Act.
See also related documents.

Inactive Ingredients:

• calcium phosphate dibasic anhydrous
• FD&C Yellow No. 6
• lactose monohydrate
• magnesium stearate
• microcrystalline cellulose
• sodium lauryl sulfate
• sodium starch glycolate type A potato

WW 120

Pill imprint WW 120 has been identified as Ergotamine tartrate and caffeine 1 mg / 100 mg.

Caffeine/ergotamine is used in the treatment of migraine; cluster headaches and belongs to the drug class antimigraine agents. Not for use in pregnancy.

Caffeine/ergotamine 1 mg / 100 mg is not subject to the Controlled Substances Act.
See also related documents.

Inactive Ingredients:

• corn starch
• sugar 6x powder
• mannitol
• compressible sugar
• microcrystalline cellulose
• silicon dioxide colloidal
• sodium starch glycolate
• magnesium
• FD&C Blue No. 2 Lake
• FD&C Yellow No. 6 Lake
• methylcellulose
• amide resin
• black pigment
• natural resin
• wax

LOGO TH

Generic Name: thyroid desiccated

Pill imprint LOGO TH has been identified as Armour thyroid 240 mg.

Armour Thyroid is used in the treatment of underactive thyroid; hypothyroidism, after thyroid removal; hashimoto’s disease; thyroid cancer; tsh suppression and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy.

Armour Thyroid 240 mg is not subject to the Controlled Substances Act.

Generic Name:

thyroid desiccated

B 293

Drug: Oxcarbazepine
Strength(s): 300 mg
Imprint: B 293
Color: Beige
Shape: Elliptical / Oval

Pill imprint B 293 has been identified as Oxcarbazepine 300 mg.

Oxcarbazepine is used in the treatment of bipolar disorder; seizures; anxiety; trigeminal neuralgia and belongs to the drug class dibenzazepine anticonvulsants. Risk cannot be ruled out during pregnancy.

Oxcarbazepine 300 mg is not subject to the Controlled Substances Act.
See also related documents.

Drug: Wellbutrin XL
Strength(s): 150 mg
Imprint: WELLBUTRIN XL 150
Color: Beige
Shape: Round

Generic Name: bupropion

Pill imprint WELLBUTRIN XL 150 has been identified as Wellbutrin XL 150 mg.

Wellbutrin XL is used in the treatment of depression; seasonal affective disorder and belongs to the drug class miscellaneous antidepressants. Risk cannot be ruled out during pregnancy.

Wellbutrin XL 150 mg is not subject to the Controlled Substances Act.
See also related documents.

Generic Name:

bupropion

Drug Class:

Miscellaneous antidepressants

Pregnancy Category:

C – Risk cannot be ruled out

CSA Schedule:

N – Not a controlled drug

Manufacturer:

GlaxoSmithKline

National Drug Code (NDC):

00173-0730

Drug: Oxycodone Hydrochloride Extended-Release
Strength(s): 80 mg
Imprint: G 164
Color: Beige
Shape: Round

Pill imprint G 164 has been identified as Oxycodone hydrochloride extended-release 80 mg.

Oxycodone is used in the treatment of pain and belongs to the drug class narcotic analgesics. FDA has not classified the drug for risk during pregnancy.

Oxycodone 80 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.

Drug: Mirtazapine
Strength(s): 30 mg
Imprint: M 530
Color: Beige
Shape: Round

Pill imprint M 530 has been identified as Mirtazapine 30 mg.

Mirtazapine is used in the treatment of depression; anxiety; insomnia; hot flashes; post traumatic stress disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy.

Mirtazapine 30 mg is not subject to the Controlled Substances Act.
See also related documents.

Drug: Enalapril Maleate
Strength(s): 20 mg
Imprint: W 926
Color: Beige
Shape: Round

Inactive Ingredients:

• stearic acid

Drug Class:

Angiotensin converting enzyme inhibitors

Pregnancy Category:

D – Positive evidence of risk

CSA Schedule:

N – Not a controlled drug

Manufacturer:

Wockhardt USA

National Drug Code (NDC):

64679-0926

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
00172-4198	Ivax Pharmaceuticals Inc
68084-0392	Amerisource Health Services
00904-5611	Major Pharmaceuticals
63304-0837	Ranbaxy Pharmaceuticals Inc.
63874-0987	Altura Pharmaceuticals Inc (repackager)
54569-5135	A S Medication Solutions LLC (repackager)
55887-0227	Diversified Healthcare Services Inc (repackager)
23490-5492	Palmetto State Pharmaceuticals Inc (repackager)
33358-0128	Core Pharmaceuticals Inc (repackager)
21695-0489	Rebel Distributors Corp (repackager)
66336-0393	Dispensing Solutions Inc. (repackager)
Note: Inactive ingredients may vary.